Details of the Drug Reposition

General Information of This Drug (ID: DMLBYRA)

Drug Name	ADX N05 DMLBYRA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Mood disorder	DISLVMWO	6A60-6E23	Phase 3	[1]
------------------------------------------------------------------------------------

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Excessive daytime sleepiness	DISI0RB1	MG42	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225)